Welcome to The Armour Group's investor page. We are a leading medical cannabis company in the UK with a mission to improve patient outcomes through responsibly using cannabis-based medicines.

At The Armour Group, we are committed to creating value for our investors and shareholders by delivering on our promise of safe, effective, high-quality medical cannabis products. Our business strategy is focused on developing innovative cannabis-based therapies and expanding our operations globally.

As an investor in The Armour Group, you will be part of a dynamic and growing industry that is expected to experience significant growth in the coming years. With the UK government legalizing medical cannabis in 2018, the market for cannabis-based medicines is expected to grow rapidly in the UK and across the globe.

Our team of experienced professionals has a track record of success in the healthcare and cannabis industries. We drive innovation and deliver results for our patients and shareholders. We believe that our expertise and commitment to quality and patient safety make us a strong partner for investors looking to enter the cannabis space.

Our financial performance has been strong, with steady revenue growth and a focus on profitability. Our sound business model is designed to capture market share and create long-term value for our investors.

The Armour Group is committed to transparency and open communication with our shareholders. We regularly update our financial performance, operational progress, and new developments in the cannabis industry. Informed investors are crucial to our success, and we strive to keep our stakeholders well informed.

We welcome your interest in The Armour Group and invite you to explore our website to learn more about our company, our strategy, and our commitment to improving patient outcomes through the responsible use of cannabis-based medicines. If you have any questions or want to learn more about investing in The Armour Group, please get in touch with us.